| CR | complete response |
| HCC | hepatocellular carcinoma |
| ICI | immune checkpoint inhibitor |
| PD | progressive disease |
| PR | partial response |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| SD | stable disease |
| TACE | transcatheter arterial chemoembolization |
| TAI | transhepatic arterial infusion |
| TKI | tyrosine kinase inhibitor |
| TNM | tumor–node–metastasis |
| VEGF | vascular endothelial growth factor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.